Meeder Asset Management Inc Galapagos Nv Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$76.15 - $111.94 $533 - $783	-7 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$96.85 - $148.25 $1,937 - $2,965	-20 Reduced 74.07%	7 $1,000
Q2 2020 Aug 11, 2020	SELL	$185.52 - $231.25 $4,452 - $5,550	-24 Reduced 47.06%	27 $5,000
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $143 - $274	1 Added 2.0%	51 $10,000
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $7,306 - $10,791	50 New	50 $10,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.